REAL

Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease

Bor, Renáta and Farkas, Klaudia and Fábián, Anna and Bálint, Anita and Milassin, Ágnes (2017) Clinical role, optimal timing and frequency of serum infliximab and anti-infliximab antibody level measurements in patients with inflammatory bowel disease. PLoS ONE, 12 (3). pp. 1-11. ISSN 1932-6203

[img]
Preview
Text
pone.0172916.pdf

Download (1MB) | Preview
Item Type: Article
Subjects: R Medicine / orvostudomány > RC Internal medicine / belgyógyászat
R Medicine / orvostudomány > RM Therapeutics. Pharmacology / terápia, gyógyszertan
Depositing User: Dr. Klaudia Farkas
Date Deposited: 08 Oct 2018 08:11
Last Modified: 05 Apr 2023 07:49
URI: http://real.mtak.hu/id/eprint/86620

Actions (login required)

Edit Item Edit Item